AMOEBA submits approval application for its biocidal active substance

In France, AMOEBA, producer of a biological biocide capable of eliminating bacterial risk in water and human wounds, and a biocontrol product for plant protection, still in trial phase, announces that a new application for approval of its biocidal active substance Willaertia magna C2c Maky has been submitted to the European Chemical Agency (ECHA). If approved, Amoéba could then consider a provisional marketing authorisation in the designated territories in the first half of 2022.

The first phase of the evaluation will be carried out by the Malta Competition and Consumer Affairs Authority (MCCAA). The active substance that has now entered the evaluation process is Willaertia magna C2c Maky amoeba in its living form, intended for use in cooling towers for the prevention of legionella growth (Product Type 11 – Preservatives for liquid-cooling and processing systems) and the control of the (Product Type 12 – Slimicides).